RxDoctor Payments Data

James Stewart, MD

Family Medicine · Hebron, KYNPI 1780785899

Payments from drug & device makers

$7,184in general payments, 2019–2025

Across 51 payments — averaging $140.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$7K
  • Amgen$171
  • AbbVie$113
  • Pfizer$57
  • Astellas Pharma US Inc$48
  • Johnson & Johnson$47
  • plus $174 from 10 others

What the payments were for

  • Consulting fees$3,30046%
  • Speaking & faculty fees$2,00028%
  • Travel & lodging$1,13616%
  • Food & beverage$74710%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,184 in reported general payments places this provider in the 90th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$45,973
Medicare patients
169
Services billed
1,892

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide53$92,217
EliquisApixaban65$60,373
Trelegy ElliptaFluticasone/Umeclidin/Vilanter47$55,610
JardianceEmpagliflozin63$53,120
JanuviaSitagliptin Phosphate15$24,279
MounjaroTirzepatide12$18,586
XareltoRivaroxaban17$16,925
Repatha SureclickEvolocumab21$14,754
SymbicortBudesonide/Formoterol Fumarate32$9,078
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen204$7,083
Breo ElliptaFluticasone/Vilanterol14$6,296
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen128$3,768
Tresiba Flextouch U-100Insulin Degludec15$3,500
Albuterol Sulfate HfaAlbuterol Sulfate136$3,397
Naproxen13$2,827

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$14$61,90661 claims
PfizerEliquis$57$60,37365 claims
MerckJanuvia$11$24,27915 claims
Lilly USA, LLCMounjaro$12$18,58612 claims
Johnson & JohnsonXarelto$47$16,92517 claims
AstraZenecaSymbicort$13$9,07832 claims
AbbVieSynthroid$113$1,42318 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Hebron

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →